Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is class III antiarrhythmic activity important?

B N Singh1

  • 1VA Medical Center WLA, CA 90073.

Cardiovascular Drugs and Therapy
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic and recent updates in nano-bioremediation for developing green technology to alleviate agricultural contaminants.

International journal of environmental science and technology : IJEST·2022
Same author

A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys.

Computers in biology and medicine·2022
Same author

How is Biodegradable Scaffold Effective in Gap Non-union? Insights from an Experiment.

Indian journal of orthopaedics·2021
Same author

Computational exploration and anti-mycobacterial activity of potential inhibitors of <i>Mycobacterium tuberculosis</i> acetyl coenzyme A carboxylase as anti-tubercular agents.

SAR and QSAR in environmental research·2021
Same author

Fabrication and evaluation of non-mulberry silk fibroin fiber reinforced chitosan based porous composite scaffold for cartilage tissue engineering.

Tissue & cell·2018
Same author

Studies on effect of CuO addition on mechanical properties and in vitro cytocompatibility in 1393 bioactive glass scaffold.

Materials science & engineering. C, Materials for biological applications·2018

Sotalol, a Class III antiarrhythmic, prolongs cardiac repolarization, offering potent antiarrhythmic effects. This action, unlike other beta blockers, results in a less negative inotropic effect, making sotalol a unique cardiac medication.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Class III antiarrhythmic action is linked to prolonged cardiac repolarization.
  • Conditions like hypothyroidism and hypocalcemia, associated with longer action potentials, show fewer arrhythmias.
  • Procainamide's acetyl metabolite prolongs action potential duration and exhibits antiarrhythmic activity.

Purpose of the Study:

  • To investigate the antiarrhythmic properties of sotalol.
  • To understand the mechanism behind sotalol's Class III antiarrhythmic action.
  • To compare sotalol's effects with other beta blockers.

Main Methods:

  • Observational studies on sotalol's effect on cardiac repolarization and conduction velocity.
  • Analysis of the relationship between action potential duration and antiarrhythmic activity.

Related Experiment Videos

  • Pharmacological characterization of sotalol's beta-adrenergic blocking and Class III properties.
  • Main Results:

    • Sotalol significantly increases cardiac repolarization time with minimal impact on conduction velocity.
    • Lengthening action potential duration is identified as an antiarrhythmic mechanism.
    • Sotalol exhibits potent Class III antiarrhythmic properties by prolonging repolarization, modulated by beta-adrenergic blockade.

    Conclusions:

    • Sotalol is a potent, broad-spectrum antiarrhythmic agent due to its Class III properties.
    • Its ability to prolong repolarization, combined with beta-adrenergic antagonism, contributes to its efficacy.
    • Sotalol has a less negative inotropic effect compared to other beta blockers, attributed to increased action potential duration and augmented tension.